See Our Clinical & Regulatory Services Portfolio Here
A Post-Market Performance Follow-up (PMPF) survey is a critical component of the In Vitro Diagnostic Regulation (IVDR) framework in the EU. These surveys are designed to collect real-world evidence on the safety, performance, and clinical effectiveness of IVD devices after they have been launched on the market.
Conducting a PMPF survey helps manufacturers:
At Cetas Healthcare, we offer end-to-end PMPF survey services—from survey design and data collection to regulatory reporting—helping you maintain IVDR compliance while enhancing patient safety and product value.
Under the IVDR, Post-Market Surveillance (PMS) refers to the comprehensive system manufacturers implement to monitor the safety and performance of in vitro diagnostic (IVD) devices after they have been placed on the market. This includes collecting and analyzing
data from various sources to ensure ongoing compliance and patient safety.
Post-Market Performance Follow-up (PMPF) is a subset of PMS, focusing specifically on proactively collecting and evaluating data to confirm the scientific validity, analytical, and clinical performance of an IVD device throughout its lifecycle. PMPF activities are designed to identify any emerging risks or performance issues that may not have been apparent during the initial conformity assessment.
Yes, the IVDR mandates that manufacturers develop and implement a PMPF plan for all IVD devices. This plan should outline the methods and procedures for proactively collecting and evaluating data on the device's performance post-market. However, if a manufacturer determines that PMPF is not necessary for a particular device, this decision must be duly justified and documented within the technical documentation.
We provide the best insights for your business